Replies to post #429456 on Amarin Corp Plc (AMRN)

[CaptBeer]

the differences between V and the placebo were not significant. That’s not to say that IPE isn’t beneficial in the long run ( really long, like 10 years), but it does say that no one will be doing a study like that any time soon. I’ve been on VASCEPA for 10 years now and I’m still doing fine.

[JRoon71]

Monk, what are you asking? There was essentially no difference between Vascepa and placebo. In fact, the placebo group actually did slightly better (which was not statistically significant).

IMO, the trial is too short, and I'm not even sure the outcome measures were appropriate. But in a short trial like this, it's all they could really measure.

As CaptBeer stated, I believe that EPA is effective over long periods of time, which is why populations with high fish intake have lower incidence of dementia. Vascepa is not an acute medication.

But outside of meta-analysis, I don't believe a long-term trial could ever be conducted like this. It would have to be VERY long, and it would have to start earlier in life.

[seve333]

I remember how hyped up Brave was on here a year ago and hyped for a long time. I never understood the hype people were acting like it was going to be huge and drive the stock to 50 bucks. Some said Denner knew what he had in Brave. I think it is safe to say at this point Denner doesn't and never had any secret weapon or master plan. He is doing the exact same thing the old management did to a T. I guess maybe he is a little better at controlling costs but other than that there are no differences that I see. It makes you wonder what the point of the nasty proxy battle even was for especially given we get even less communication from denner.